[Tyr0]-Hypercalcemia Malignancy Factor (1-40) is a tyrosine-extended analog of a PTH-related peptide region, designed for enhanced detection and conjugation. The added residue provides a chromophoric handle without disrupting the main regulatory domain. Its structure supports investigations of PTH-related protein signaling. Researchers employ it in receptor-binding and peptide trafficking studies.
CAT No: P03044
3. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy
4. Emu oil in combination with other active ingredients for treating skin imperfections
5. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More